Human leukocyte antigen-G polymorphism influences the age of onset and autoantibody status in rheumatoid arthritis

Tissue Antigens

Volumn 85, Issue 3, 2015, Pages 182-189

  Mariaselvam, C M ^a,b   Chaaben, A B ^b   Salah, S ^b   Charron, D ^b   Krishnamoorthy, R ^b   Tamouza, R ^b   Negi, V S ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

HLA G polymorphism; late onset rheumatoid arthritis; Rheumatoid arthritis; Rheumatoid factor; Young onset rheumatoid arthritis

Indexed keywords

AUTOANTIBODY; GENOMIC DNA; HUMAN LEUKOCYTE ANTIGEN G; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN M; LEUKOCYTE ANTIGEN; METHOTREXATE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; HLA G ANTIGEN;

3' UNTRANSLATED REGION; ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DAS28; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; INDIAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ONSET AGE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT RESPONSE; ALLELE; ARTHRITIS, RHEUMATOID; BLOOD; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INDIA; PATHOLOGY; RISK FACTOR; SEX DIFFERENCE;

3' UNTRANSLATED REGIONS; ADULT; AGE OF ONSET; ALLELES; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-G ANTIGENS; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RHEUMATOID FACTOR; RISK FACTORS; SEX FACTORS;

EID: 84923323337     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12521     Document Type: Article

References (52)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003: 423: 356-61.
2. Nielen MM, van Schaardenburg D, Reesink HW et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004: 50: 380-6.
3. Rantapaa-Dahlqvist S, de Jong BA, Berglin E et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003: 48: 2741-9.
4. Silman AJ, MacGregor AJ, Thomson W et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 1993: 32: 903-7.
5. Seldin MF, Amos CI, Ward R, Gregersen PK. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 1999: 42: 1071-9.
6. Yamada R, Yamamoto K. Mechanisms of disease: genetics of rheumatoid arthritis-ethnic differences in disease-associated genes. Nat Clin Pract Rheumatol 2007: 3: 644-50.
7. Fernando MM, Stevens CR, Walsh EC et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 2008: 4: e1000024.
8. Seidl C, Koch U, Buhleier T et al. HLA-DRB1*04 subtypes are associated with increased inflammatory activity in early rheumatoid arthritis. Br J Rheumatol 1997: 36: 941-4.
9. Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 1994: 56: 389-466.
10. van der Helm-van Mil AH, Huizinga TW, Schreuder GM, Breedveld FC, de Vries RR, Toes RE. An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility. Arthritis Rheum 2005: 52: 2637-44.
11. MacGregor AJ, Snieder H, Rigby AS et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000: 43: 30-7.
12. Curigliano G, Criscitiello C, Gelao L, Goldhirsch A. Molecular pathways: human leukocyte antigen G (HLA-G). Clin Cancer Res 2013: 19: 5564-71.
13. Fainardi E, Castellazzi M, Stignani M et al. Emerging topics and new perspectives on HLA-G. Cell Mol Life Sci 2011: 68: 433-51.
14. Morandi F, Pistoia V. Interactions between HLA-G and HLA-E in physiological and pathological conditions. Front Immunol 2014: 5: 394.
15. Paul P, Cabestre FA, Ibrahim EC et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 2000: 61: 1138-49.
16. Rizzo R, Farina I, Bortolotti D et al. HLA-G may predict the disease course in patients with early rheumatoid arthritis. Hum Immunol 2013: 74: 425-32.
17. Catamo E, Addobbati C, Segat L et al. HLA-G gene polymorphisms associated with susceptibility to rheumatoid arthritis disease and its severity in Brazilian patients. Tissue Antigens 2014: 84: 308-15.
18. Veit TD, Vianna P, Scheibel I et al. Association of the HLA-G 14-bp insertion/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis. Tissue Antigens 2008: 71: 440-6.
19. Lucena-Silva N, de Souza VS, Gomes RG et al. HLA-G 3' untranslated region polymorphisms are associated with systemic lupus erythematosus in 2 Brazilian populations. J Rheumatol 2013: 40: 1104-13.
20. Consiglio CR, Veit TD, Monticielo OA et al. Association of the HLA-G gene +3142C>G polymorphism with systemic lupus erythematosus. Tissue Antigens 2011: 77: 540-5.
21. Rizzo R, Hviid TV, Govoni M et al. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 2008: 71: 520-9.
22. Borghi A, Rizzo R, Corazza M et al. HLA-G 14-bp polymorphism: a possible marker of systemic treatment response in psoriasis vulgaris? Preliminary results of a retrospective study. Dermatol Ther 2014: 27: 284-9.
23. Rizzo R, Bortolotti D, Fredj NB et al. Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. Hum Immunol 2012: 73: 1140-6.
24. Larsen MH, Hviid TV. Human leukocyte antigen-G polymorphism in relation to expression, function, and disease. Hum Immunol 2009: 70: 1026-34.
25. Hviid TV, Hylenius S, Rorbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003: 55: 63-79.
26. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003: 64: 1005-10.
27. Chen XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX. The 14bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 2008: 72: 335-41.
28. Yie SM, Xiao R, Librach CL. Progesterone regulates HLA-G gene expression through a novel progesterone response element. Hum Reprod 2006: 21: 2538-44.
29. Verbruggen LA, Rebmann V, Demanet C, De Cock S, Grosse-Wilde H. Soluble HLA-G in rheumatoid arthritis. Hum Immunol 2006: 67: 561-7.
30. Rizzo R, Rubini M, Govoni M et al. HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis. Pharmacogenet Genomics 2006: 16: 615-23.
31. Ongaro A, Stignani M, Pellati A et al. Human leukocyte antigen-G molecules are constitutively expressed by synovial fibroblasts and upmodulated in osteoarthritis. Hum Immunol 2010: 71: 342-50.
32. Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol 2008: 29: 125-32.
33. Malaviya AN, Kapoor SK, Singh RR, Kumar A, Pande I. Prevalence of rheumatoid arthritis in the adult Indian population. Rheumatol Int 1993: 13: 131-4.
34. Chopra A, Patil J, Billempelly V, Relwani J, Tandle HS. Diseases W-ICSWILoAfRCOPfCoR. Prevalence of rheumatic diseases in a rural population in western India: a WHO-ILAR COPCORD Study. J Assoc Physicians India 2001: 49: 240-6.
35. Aletaha D, Neogi T, Silman AJ et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010: 62: 2569-81.
36. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995: 38: 44-8.
37. van Gestel AM, Prevoo ML, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996: 39: 34-40.
38. van Riel PL, van Gestel AM, van de Putte LB. Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers. Br J Rheumatol 1996: 35 (Suppl 2): 4-7.
39. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
40. Tan Z, Randall G, Fan J et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 2007: 81: 829-34.
41. Veit TD, Chies JA. Tolerance versus immune response - microRNAs as important elements in the regulation of the HLA-G gene expression. Transpl Immunol 2009: 20: 229-31.
42. Castelli EC, Moreau P, Oya e Chiromatzo A et al. In silico analysis of microRNAS targeting the HLA-G 3' untranslated region alleles and haplotypes. Hum Immunol 2009: 70: 1020-5.
43. Veit TD, de Lima CP, Cavalheiro LC et al. HLA-G +3142 polymorphism as a susceptibility marker in two rheumatoid arthritis populations in Brazil. Tissue Antigens 2014: 83: 260-6.
44. Kim SK, Chung JH, Kim DH, Yun DH, Hong SJ, Lee KH. Lack of association between promoter polymorphisms of HLA-G gene and rheumatoid arthritis in Korean population. Rheumatol Int 2012: 32: 509-12.
45. Lee YH, Bae SC, Song GG. Meta-analysis of associations between functional HLA-G polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis. Rheumatol Int 2014 Oct 18 (Epub ahead of print).
46. Jansen LM, van der Horst-Bruinsma IE, van Schaardenburg D, Bezemer PD, Dijkmans BA. Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann Rheum Dis 2001: 60: 924-7.
47. Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD, Tanasescu R. Extra-articular manifestations in rheumatoid arthritis. Maedica 2010: 5: 286-91.
48. Zamani M, Spaepen M, Sghar SS et al. Linkage and association of HLA class II genes with vitiligo in a Dutch population. Br J Dermatol 2001: 145: 90-4.
49. Kooloos WM, Wessels JA, van der Straaten T, Allaart CF, Huizinga TW, Guchelaar HJ. Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis. Pharmacogenomics 2010: 11: 163-75.
50. Stamp LK, O'Donnell JL, Chapman PT et al. Lack of association between HLA-G 14bp insertion/deletion polymorphism and response to long-term therapy with methotrexate response in rheumatoid arthritis. Ann Rheum Dis 2009: 68: 154-5.
51. Martelli-Palomino G, Pancotto JA, Muniz YC et al. Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population. PLoS One 2013: 8: e71742.
52. Sabbagh A, Luisi P, Castelli EC et al. Worldwide genetic variation at the 3' untranslated region of the HLA-G gene: balancing selection influencing genetic diversity. Genes Immun 2014: 15: 95-106.